看板 CSMU-MED93 關於我們 聯絡資訊
我陽明的同學不確定是不是劉仁賢教的,範圍又有點不像,所以大家參考就好了 或者可以去FTP血腫資料夾==>共筆完稿區==>陽明PET共筆 下載 共筆最後面就是這份考古題 1. Which of the followings is not the role of nuclear medicine imaging in oncology diagnosis? (A) Screening (B) Staging (C) Monitoring (D) prognosis (E) Tumor genotyping 2. Which of the followings are specific techniques of nuclear medicine imaging? I. Tc-99m sulfur colloid liver imaging II. Tc-99m DMSA renal imaging III. Tc-99m MDP bone scan IV. I-131-MIBG imaging V. F-18-FDG imaging (A) I and III (B) IV and V (C) III and IV (D) II and V (E) I and II 3. The mechanism of Ga-67 tumor imaging is: (A) Ga-67 _ binding globulin _ cell membrane receptor (B) Ga-67 _ binding transferrin _ internalization with iron in malignant cells (C) Ga-67 _ binding transferrin _ transferrin receptors on tumor cells _ Ferritin internalization (D) Ga-67 _ binding serum albumin _ passive diffusion into tumor cells _ Ferritin internalization (E) Ga-67 _ passive diffusion into tumor cells _ internalization with iron 4. Which of the following nuclear medicine imagings has the potential to detect multidrug resistance in tumors? (A) Ga-67 tumor scan (B) T1-201 tumor scan (C) F-18-FDG PET scan (D) In-111-octerotide imaging (E) Tc-99m-MIBI tumor 5. Which of the following nuclear medicine imagings is highly specific to detect functioning adrenal medullary tumor? (A) I-131-MIBG imaging (B) Tc-99m-DMSA imaging (C) F-18-FDG PET scan (D) Ga-67 imaging (E) Tc-99m-MIBI imaging 6. Which of the following is the exception of the most popular positron emitting radionuclide for clinical use? (A) O-15 (B) N-13 (C) C-11 (D) F-18 (E) Tc-94m 7. The followings are the capability of different imaging modalities for assessing the tumor metabolism arrayed from the most powerful to the least. Please choose a right answer. (A) PET, SPECT, MRI, CT (B) PET, MRI, SPECT, CT (C) MRI, PET, SPECT, CT (D) MRI, PET, CT, SPECT (E) SPECT, PET, MRI, CT 8. Which of the followings is not the potential usage of PET for assessment of tumor behavior? (A) Tumor tissue composition (B) Cell proliferation (C) Tumor hypoxia (D) Nuclear genetics (E) Hexokinase activity 9. Which of the followings is not the benefit of PET in the pre-operative staging of non-small cell carcinoma of lung? (A) 12% of patients with tumor being changed form malignant to benign (B) 11% of patients with lymph nodes enlargement being changed to be surgical removable of primary tumor due to negative results of PET imaging (C) 19% patients being excluded from surgery due to distant metastases detected by PET (D) Patients without PET evidence of nodal involvement can not exclude CT or MRI examination of mediastinum (E) The decision of surgical treatment may be changed by PET in about 58% of patiients 10. Which of the followings is not the role of molecular imaging in the management of cancer? (A) Imaging of biomarker for early diagnosis (B) Assess tumor receptors, signal transduction, and apoptosis (C) Assess angiogenesis, proliferation (D) Assess polarity of tumor cell membrane (E) Assess drug target expression and activity 答案: EBCEAEBAED -- ※ 發信站: 批踢踢實業坊(ptt.cc) ◆ From: 218.162.89.251
suiam74:亞涵辛苦囉~^^ 10/11 18:59
tabo0:辛苦了~ 10/12 19:13